Bismuth subcitrate
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171928This classification denotes a cytoprotective agent and anti-ulcer agent with the molecular formula 2C6H5O7.Bi.3K, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HS813P8QPX, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) potassium salt (2:1:3) but generally known as bismuth subcitrate, which bears US NIH Compound Identifier 6335486. European Medicines Agency schedules Bismuth subcitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13089MIG. World Health Organization schedules bismuth subcitrate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, BISMUTH SUBCITRATE remains the US FDA Preferred Term for this commodity. Bismuth subcitrate bears US NLM identifiers UMLS ID C0106556 and NCI Concept Code C1351. SMILES: C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Bi+3].
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.